DHEA is the hope for infertile women!
Read this link.
A study performed by Israeli researchers has confirmed the results of a New York research team about the effects of dehydroepiandrosterone, the supplement known in layman's lingo as DHEA, on female infertility when used to treat women suffering from DOR (diminished ovarian reserves). The Israeli team hails from the Tel Aviv University in Tel Aviv, Israel and is led by Adrian Shulman, MD, while the previous studies were performed by the scientists at New York City's Center for Human Reproduction (CHR).
While the Israeli study is small and includes only 33 participants, this work is the only random study on DHEA as a therapy for female factor infertility. Of the participants in this study, 17 were given the supplement while a second group of 16 women stood in as a control group. The results of the study confirmed that DHEA triples the success rate for women who conceive by in vitro fertilization (IVF).